Alfred Altomari is Chief Executive Officer of AGILE THERAPEUTICS INC. Currently has a direct ownership of 0 shares of AGRX, which is worth approximately $0. The most recent transaction as insider was on Aug 26, 2024, when has been sold 47,749 shares (Common Stock) at a price of $1.52 per share, resulting in proceeds of $72,578. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

ALFRED ALTOMARI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2024
SELL
Sale (or disposition) back to the issuer
$72,578 $1.52 p/Share
47,749 Reduced 100.0%
0 Common Stock
Jun 28 2023
BUY
Grant, award, or other acquisition
-
46,463 Added 49.32%
47,749 Common Stock
Aug 26 2022
BUY
Open market or private purchase
$22,500 $0.45 p/Share
50,000 Added 43.73%
64,343 Common Stock
Oct 13 2021
BUY
Open market or private purchase
-
58,824 Added 9.3%
573,734 Common Stock
Jul 29 2021
BUY
Open market or private purchase
$33,012 $1.26 p/Share
26,200 Added 4.84%
514,910 Common Stock
May 18 2021
BUY
Open market or private purchase
$32,200 $1.61 p/Share
20,000 Added 3.93%
488,710 Common Stock
Mar 23 2021
BUY
Open market or private purchase
$25,000 $2.0 p/Share
12,500 Added 2.6%
468,710 Common Stock

Also insider at

BXRX
Baudax Bio, Inc. Healthcare
INSM
INSMED Inc Healthcare
AA

Alfred Altomari

Chief Executive Officer
Princeton, NJ

Track Institutional and Insider Activities on AGRX

Follow AGILE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGRX shares.

Notify only if

Insider Trading

Get notified when an Agile Therapeutics Inc insider buys or sells AGRX shares.

Notify only if

News

Receive news related to AGILE THERAPEUTICS INC

Track Activities on AGRX